CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

23 hedge funds and large institutions have $20.9M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.2M
2
$1.26M
3
$1.17M
4
$859K
5
$567K
6
$362K
7
$328K
8
$216K
9
$197K
10
$194K
11
$193K
12
$136K
13
$74K
14
$65K
15
$42K
16
$39K
17
$26K
18
$22K
19
$22K
20
$8K
21
$5K
22
$2K
23
24
25